๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hypolipemiant besides antileukemic effect of imatinib mesylate

โœ Scribed by Radu Gologan; Gabriela Constantinescu; Daniela Georgescu; Daniela Ostroveanu; Didona Vasilache; Camelia Dobrea; Daniela Iancu; Viola Popov


Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
101 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of age on prognosis with imatini
โœ Jorge Cortes; Moshe Talpaz; Susan O'Brien; Francis Giles; Mary Beth Rios; Jianqu ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 121 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Older age is a consistent poor prognostic factor in patients with Philadelphia chromosome (Ph)โ€positive chronic myelogenous leukemia (CML). Whether this is related to an intrinsic worse disease biology or to inadequate drug delivery or excessive treatmentโ€associated toxic